Search results
Results from the WOW.Com Content Network
Alive & Well AIDS Alternatives (formerly HEAL, Health Education AIDS Liaison) is a 501(c) non-profit organization of AIDS denialists. [1] The organization's stated mission is to "present information that raises questions about the accuracy of HIV tests, the safety and effectiveness of AIDS drug treatments, and the validity of most common assumptions about HIV and AIDS."
The HIV Prevention Trials Network conducted a clinical trial, HPTN 052, that analyzed the effectiveness of antiretroviral drugs on the HIV-1 virus. 1,783 HIV sero-discordant couples, or couples that consist of an HIV-positive individual and an HIV-negative partner, from nine different countries were a part of the study, 97% of the couples being ...
There are several treatment guidelines for HIV-1 infected adults in the developed world (that is, those countries with access to all or most therapies and laboratory tests). In the United States there are both the International AIDS Society-USA (IAS-USA) (a 501(c)(3) not-for-profit organization in the US) [ 47 ] as well as the US government's ...
Ready, Set, PrEP is a program of the U.S. Department of Health and Human Services (HHS) that provides free access to the HIV prevention medication PrEP for thousands of qualifying individuals. The program is a key component of Ending the HIV Epidemic: A Plan for America (EHE) initiative to expand access to PrEP and reduce new HIV diagnoses in ...
Although HIV PrEP medications are only available in oral tablet and injectable formulations, other formulations are being developed and studied. The emerging treatments expand HIV prevention strategies for women. For example, a vaginal gel formulation of tenofovir and an intravaginal ring releasing dapivirine are under investigation for ...
The organization was created when Taylor and Gottleib’s California-based National AIDS Research Foundation, [5] which sought to actively engage in HIV-related drug development, [6] merged with Krim’s New York-based AIDS Medical Foundation (AMF), which sought to lessen the stigma surrounding HIV/AIDS diagnoses, as well as to increase funding ...
PEPFAR directly supported 83.8 million people with HIV testing services an increase of 12 million more people since 2023 in which 71 million people were test in fiscal year 2023. [30] [26] PEPFAR supported antiretroviral drug prophylaxis to prevent mother-to-child transmission (MTCT), resulting in 5.5 million babies born HIV-free. [31]
Nucleic-acid-based tests amplify and detect one or more of several target sequences located in specific HIV genes, such as HIV-I GAG, HIV-II GAG, HIV-env, or the HIV-pol. [32] [33] Since these tests are relatively expensive, the blood is screened by first pooling some 8–24 samples and testing these together; if the pool tests positive, each ...